Our mission is to digitize, decode, and decipher human biology for the prevention, early diagnosis, and treatment of chronic diseases and cancer.
Increasing every day, Viome boasts access to an mRNA platform of more than a quarter million samples to generate and test hypotheses related to many chronic diseases and cancers. At our core, Viome focuses on establishing biological data trends that identify the patterns for optimal health. Our initiative integrates a robust dataset with innovative technology to determine causal relationships that evaluate and improve the current understanding of chronic diseases as we know them.
Insight to Intervention
Our direct-to-consumer service analyzes gene expressions (mRNA) in order to provide individuals with health insights and precision nutrition to live a healthier life.
This platform of over 300,000 samples enables us to enhance our understanding of human biology as a system in order to develop predictive biomarkers, precision diagnostics, and precision therapeutics to prevent and intercept chronic diseases.
Clinical improvements in IBS, Diabetes, Depression & Anxiety.
Our predictive biomarkers provide us with the hypothesis to do clinical research and identify the signatures of chronic diseases, cancers, and aging.
Successfully developed over 30 predictive models for Glycemic response, Obesity, Diabetes, Depression, IBS, and Oral Cancer, which represent over 50% of chronic diseases.
FDA Breakthrough Device Designation for oral & throat cancer to detect early-stage throat cancer and oral cancer with 95% specificity and 90% plus sensitivity.
The signatures found through diagnostics allow us to determine the mechanism of action to develop precision therapeutics in the form of drugs and vaccines.
Viome can determine drug effectiveness, including immunotherapy, which is dependent upon the gut microbiome.
Contracts with large pharma company to develop vaccines for colorectal cancer and an autoimmune disease.
Viome transforms samples into
effective Dx and Tx
Viome Health Sciences R&D efforts focused on diseases with high unmet need
Utilizing Human Gene Expression And Microbial To Identify New Biomarkers For Targeted Therapeutics
Integration of new data insights accumulated from our consumer platform are readily evolving and expanding the current understanding of chronic disease prevention, prediction, diagnostics, prognostics, and therapeutics.
Collaborations for therapeutics and opportunities to
improve speed, cost and risk for partners